Skip to main content
. 2017 Aug 25;7:9499. doi: 10.1038/s41598-017-09810-0

Table 2.

The summary of prediction scores for nonsynonymous substitutions in the GCK amino acid sequence, for which data were available either on their clinical phenotype, the GSIR-T or the Hill coefficient. For a detailed list of nonsynonymous substitutions analyzed, relevant raw data and references, cf. Table S2.

Measure Prediction method: Variable SIFT PolyPhen2 PhD-SNP PoPMuSiC 2.1 SNAP2 SNPs&GO (GO terms excluded) SNPs&GO (GO terms included) I-Mutant 3 Align GVGD EVmutation
Disease
PHHI (n = 16) Sensitivity [%] 63 94 44 94 25 13 56 81 81 75
Non-diabetic (n = 16) Sensitivity [%] 75 38 75 27 88 94 50 20 50 N/A (53)
Non-diabetic (n = 515) False positive ratio [%] 13.2 5.2 15.7 5.5 23.7 28.0 11.1 15.5 9.5 3.6
MODY (n = 499) Sensitivity [%] 87.6 94.8 85.6 94.5 78.0 66.9 87.0 84.6 75.6 97.1
GSIR-T
<4 (n = 19) Sensitivity [%] 63 95 53 100 32 13 39 84 84 72
4–5.5 (n = 20; normal range) Sensitivity [%] 25 10 35 15 40 55 30 20 15 5
4–5.5 (n = 106) False positive ratio [%] 28 3 15 4 27 29 16 14 7 8
>5.5 (n = 87) Sensitivity [%] 92 98 93 95 82 71 89 86 95 97
Hill coefficient n H
<1.2 (n = 23) Sensitivity [%] 96 91 96 100 87 74 96 87 96 100
1.2–1.5 (n = 48) Sensitivity [%] 83 96 79 94 69 50 77 88 94 94
>1.5 (n = 56; normal range) Sensitivity [%] 18 4 23 5 36 39 23 14 11 11
>1.5 (n = 71) False positive ratio [%] 13 4 15 4 25 30 15 13 6 4

PoPMuSiC2.1 and I-Mutant 3 were only calculated for amino acids available in the crystal structure (PDB ID: 1V4S). Calculations for some amino acids were not available for the EVmutation. The threshold value for EVmutation was set to a median value of normoglycemic variations (−2.39) as all but two neutral nonsynonymous substitutions exceeded the originally suggested zero threshold11.